Literature DB >> 20966416

Distinctive RNA expression profiles in blood associated with white matter hyperintensities in brain.

Huichun Xu1, Boryana Stamova, Glen Jickling, Yingfang Tian, Xinhua Zhan, Bradley P Ander, Dazhi Liu, Renée Turner, Jonathan Rosand, Larry B Goldstein, Karen L Furie, Piero Verro, S Claiborne Johnston, Frank R Sharp, Charles S Decarli.   

Abstract

BACKGROUND AND
PURPOSE: White matter hyperintensities (WMH) are areas of high signal detected by T2 and fluid-attenuated inversion recovery sequences on brain MRI. Although associated with aging, cerebrovascular risk factors, and cognitive impairment, the pathogenesis of WMH remains unclear. Thus, RNA expression was assessed in the blood of individuals with and without extensive WMH to search for evidence of oxidative stress, inflammation, and other abnormalities described in WMH lesions in brain.
METHODS: Subjects included 20 with extensive WMH (WMH+), 45% of whom had Alzheimer disease, and 18 with minimal WMH (WMH-), 44% of whom had Alzheimer disease. All subjects were clinically evaluated and underwent quantitative MRI. Total RNA from whole blood was processed on human whole genome Affymetrix HU133 Plus 2.0 microarrays. RNA expression was analyzed using an analysis of covariance.
RESULTS: Two hundred forty-one genes were differentially regulated at ± 1.2-fold difference (P < 0.005) in subjects with WMH+ as compared to WMH-, regardless of cognitive status and 50 genes were differentially regulated with ± 1.5-fold difference (P < 0.005). Cluster and principal components analyses showed that the expression profiles for these genes distinguished WMH+ from WMH- subjects. Function analyses suggested that WMH-specific genes were associated with oxidative stress, inflammation, detoxification, and hormone signaling, and included genes associated with oligodendrocyte proliferation, axon repair, long-term potentiation, and neurotransmission.
CONCLUSIONS: The unique RNA expression profile in blood associated with WMH is consistent with roles of systemic oxidative stress and inflammation, as well as other potential processes in the pathogenesis or consequences of WMH.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20966416      PMCID: PMC3694808          DOI: 10.1161/STROKEAHA.110.591875

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  28 in total

1.  Lack of difference in brain hyperintensities between patients with early Alzheimer's disease and control subjects.

Authors:  T Erkinjuntti; F Gao; D H Lee; M Eliasziw; H Merskey; V C Hachinski
Journal:  Arch Neurol       Date:  1994-03

2.  The cognitive correlates of white matter abnormalities in normal aging: a quantitative review.

Authors:  F M Gunning-Dixon; N Raz
Journal:  Neuropsychology       Date:  2000-04       Impact factor: 3.295

3.  Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study.

Authors:  H Wolf; G M Ecke; S Bettin; J Dietrich; H J Gertz
Journal:  Int J Geriatr Psychiatry       Date:  2000-09       Impact factor: 3.485

4.  White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity.

Authors:  P Scheltens; F Barkhof; J Valk; P R Algra; R G van der Hoop; J Nauta; E C Wolters
Journal:  Brain       Date:  1992-06       Impact factor: 13.501

5.  Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease.

Authors:  Y Tang; A Lu; B J Aronow; F R Sharp
Journal:  Ann Neurol       Date:  2001-12       Impact factor: 10.422

6.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

7.  Inflammatory biomarkers of vascular risk as correlates of leukoariosis.

Authors:  Clinton B Wright; Yeseon Moon; Myunghee C Paik; Truman R Brown; LeRoy Rabbani; Mitsuhiro Yoshita; Charles DeCarli; Ralph Sacco; Mitchell S V Elkind
Journal:  Stroke       Date:  2009-08-20       Impact factor: 7.914

8.  Regional pattern of white matter microstructural changes in normal aging, MCI, and AD.

Authors:  D Y Lee; E Fletcher; O Martinez; M Ortega; N Zozulya; J Kim; J Tran; M Buonocore; O Carmichael; C DeCarli
Journal:  Neurology       Date:  2009-10-21       Impact factor: 9.910

9.  Interaction of medial temporal lobe atrophy and white matter hyperintensities in AD.

Authors:  W M van der Flier; H A M Middelkoop; A W E Weverling-Rijnsburger; F Admiraal-Behloul; A Spilt; E L E M Bollen; R G J Westendorp; M A van Buchem
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910

10.  MAP1B is required for axon guidance and Is involved in the development of the central and peripheral nervous system.

Authors:  A Meixner; S Haverkamp; H Wässle; S Führer; J Thalhammer; N Kropf; R E Bittner; H Lassmann; G Wiche; F Propst
Journal:  J Cell Biol       Date:  2000-12-11       Impact factor: 10.539

View more
  25 in total

Review 1.  All's well that transcribes well: non-coding RNAs and post-stroke brain damage.

Authors:  Raghu Vemuganti
Journal:  Neurochem Int       Date:  2013-08-15       Impact factor: 3.921

2.  Astrocytic hypertrophy in anterior cingulate white matter of depressed suicides.

Authors:  Susana G Torres-Platas; Christa Hercher; Maria Antonietta Davoli; Gilles Maussion; Benoit Labonté; Gustavo Turecki; Naguib Mechawar
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

Review 3.  Blood biomarkers of ischemic stroke.

Authors:  Glen C Jickling; Frank R Sharp
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

Review 4.  Association between Leukoaraiosis and Poor Outcome is not due to Reperfusion Inefficiency after Intravenous Thrombolysis.

Authors:  Genlong Zhong; Shenqiang Yan; Sheng Zhang; Qingmeng Chen; Yangxiao Lai; Min Lou
Journal:  Transl Stroke Res       Date:  2016-06-02       Impact factor: 6.829

5.  FLAIR and diffusion MRI signals are independent predictors of white matter hyperintensities.

Authors:  P Maillard; O Carmichael; D Harvey; E Fletcher; B Reed; D Mungas; C DeCarli
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-14       Impact factor: 3.825

Review 6.  Whole genome expression of cellular response to stroke.

Authors:  Frank R Sharp; Glen C Jickling
Journal:  Stroke       Date:  2013-06       Impact factor: 7.914

7.  Brain iron deposition in white matter hyperintensities: a 3-T MRI study.

Authors:  Shenqiang Yan; Jianzhong Sun; Yi Chen; Magdy Selim; Min Lou
Journal:  Age (Dordr)       Date:  2012-11-07

Review 8.  The pathobiology of vascular dementia.

Authors:  Costantino Iadecola
Journal:  Neuron       Date:  2013-11-20       Impact factor: 17.173

9.  Distinctive RNA expression profiles in blood associated with Alzheimer disease after accounting for white matter hyperintensities.

Authors:  Zhouxian Bai; Boryana Stamova; Huichun Xu; Bradley P Ander; Jiajia Wang; Glen C Jickling; Xinhua Zhan; DaZhi Liu; Guangchun Han; Lee-Way Jin; Charles DeCarli; Hongxing Lei; Frank R Sharp
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Jul-Sep       Impact factor: 2.703

10.  Integrative Multi-omics Analysis to Characterize Human Brain Ischemia.

Authors:  Laura Ramiro; Teresa García-Berrocoso; Ferran Briansó; Leire Goicoechea; Alba Simats; Víctor Llombart; Ricardo Gonzalo; Alexandre Hainard; Elena Martínez-Saez; Francesc Canals; Jean-Charles Sanchez; Alex Sánchez-Pla; Joan Montaner
Journal:  Mol Neurobiol       Date:  2021-05-03       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.